Literature DB >> 2568887

Expression of the v-erbA product, an altered nuclear hormone receptor, is sufficient to transform erythrocytic cells in vitro.

O Gandrillon1, P Jurdic, B Pain, C Desbois, J J Madjar, M G Moscovici, C Moscovici, J Samarut.   

Abstract

We investigated the effect of the v-erbA oncogene product, an altered thyroid hormone receptor, in chicken erythrocyte progenitor cells. Bone marrow cells were infected with a retrovirus vector (XJ12) carrying the v-erbA gene in association with the neoR gene. XJ12-infected erythrocyte progenitor cells gave rise to G418-resistant clones. Some were composed of blast cells identified as transformed CFU-Es blocked in their differentiation. These cells could be grown in culture for at least 25 generations and required anemic chicken serum as a source of erythropoietic growth factors. XJ12 can infect erythrocyte progenitor cells in vivo but is not sufficient to induce erythroleukemia. These data suggest that the activation of a nuclear hormone receptor might represent one step toward the development of neoplasms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568887     DOI: 10.1016/0092-8674(89)90408-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

2.  A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.

Authors:  M Altabef; M Garcia; C Lavau; S C Bae; A Dejean; J Samarut
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

6.  Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.

Authors:  A Baniahmad; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro.

Authors:  M Garcia; H de Thé; P Tiollais; J Samarut; A Dejean
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

8.  v-erbA acts on retinoic acid receptors in immature avian erythroid cells.

Authors:  S Sande; M Sharif; H Chen; M Privalsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

Authors:  F Saatcioglu; P Bartunek; T Deng; M Zenke; M Karin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.